SPY002-072

DRUG2 trials

Sponsors

Spyre Therapeutics, Inc.

Conditions

AxSpAAxial SpondyloarthritisHealthyPsA (Psoriatic Arthritis)Psoriatic ArthritisRheumatic DiseasesRheumatic Joint DiseaseRheumatoid Arthritis

Phase 1

A Study of SPY002-072 in Healthy Volunteers

CompletedNCT06622070

Spyre Therapeutics, Inc.Healthy

Start: 2024-11-18End: 2026-07-28Updated: 2026-08-25

Phase 2

A Study of SPY072 in Rheumatic Disease

Active, not recruitingNCT07148414

Spyre Therapeutics, Inc.Axial Spondyloarthritis, AxSpA, PsA (Psoriatic Arthritis) +5

Start: 2025-08-21End: 2028-03-31Target: 285Updated: 2026-06-05